Pages that link to "Q52961542"
Jump to navigation
Jump to search
The following pages link to The New Zealand Intensive Medicines Monitoring Programme. (Q52961542):
Displaying 25 items.
- Data quality management in pharmacovigilance (Q30959027) (← links)
- Signal generation in the New Zealand Intensive Medicines Monitoring Programme: a combined clinical and statistical approach (Q34692920) (← links)
- Issues in the approval of, access to, and post-marketing follow-up of new drugs in Canada: a personal viewpoint. (Q34759698) (← links)
- Risk management from an Asian/Pacific Rim regulatory perspective (Q35778948) (← links)
- A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP). (Q36053274) (← links)
- Spontaneous reporting--of what? Clinical concerns about drugs (Q36053599) (← links)
- Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey (Q36171629) (← links)
- Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study (Q36907167) (← links)
- Pharmacovigilance: methods, recent developments and future perspectives (Q37181786) (← links)
- Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study (Q37319463) (← links)
- Modern methods of pharmacovigilance: detecting adverse effects of drugs (Q37626687) (← links)
- Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania (Q39941785) (← links)
- Activation of Pain by Sumatriptan (Q44597405) (← links)
- Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study (Q44598999) (← links)
- Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information. (Q45921748) (← links)
- Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. (Q45937737) (← links)
- Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand (Q46561624) (← links)
- Clinical perspectives in drug safety and adverse drug reactions (Q46975372) (← links)
- Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study (Q48463374) (← links)
- Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women (Q78709678) (← links)
- Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? (Q78772969) (← links)
- Ethically speaking: issues in the postmarketing evaluation of pharmaceuticals (Q81764026) (← links)
- Drug metabolism genotypes and their association with adverse drug reactions in selected populations: a pilot study of methodology (Q82691186) (← links)
- The Fatal Love of Forms (Q84550802) (← links)
- Intensive Monitoring Studies for Assessing Medicines: A Systematic Review (Q92409454) (← links)